Cancer Immunology, Immunotherapy

, Volume 54, Issue 3, pp 265–272 | Cite as

Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer

  • Henriette Ytting
  • Ib Jarle Christensen
  • Jens Christian Jensenius
  • Steffen Thiel
  • Hans Jørgen Nielsen
Original Article

Abstract

Purpose: Deficiency of the mannan-binding lectin (MBL) pathway of innate immunity is associated with increased susceptibility to infections. In patients with colorectal cancer (CRC), postoperative infection is associated with poor prognosis. The aim of the present study was to evaluate (1) the relation between the MBL pathway and postoperative infectious complications and survival of patients resected for CRC, and (2) the role of MBL in acute phase response compared to C-reactive protein (CRP). Methods: Preoperative MBL concentration, MBL-associated serine protease (MBL/MASP) activity and CRP were determined in serum from 611 patients and 150 healthy controls. The patients were observed for 8 years. Postoperative infections, recurrence and survival were recorded. Results: The MBL pathway components were increased in the patients compared with the healthy controls (p<0.0001). Low MBL levels were predictive of pneumonia (p=0.01), and pneumonia (n=87) was associated with poor survival (p=0.003; HR=1.5; 95% CI, 1.1 to 1.9). MBL and MBL/MASP activity showed no correlation with CRP (Spearman’s ρ=0.02; 95% CI, −0.06 to 0.10). Conclusion: Low preoperative MBL levels are predictive of pneumonia, which is associated with poorer survival. MBL concentration and MBL/MASP activity was not predictive of other postoperative infections or long-term prognosis, and showed no correlation with CRP.

Keywords

Colorectal cancer Complement Infectious complications MBL Prognosis Survival 

References

  1. 1.
    Aittoniemi J, Rintala E, Miettinen A et al (1997) Serum mannan-binding lectin (MBL) in patients with infection: clinical and laboratory correlates. APMIS 105:617–622PubMedGoogle Scholar
  2. 2.
    Faist E (1996) The mechanisms of host defense dysfunction following shock and trauma. Curr Top Microbiol Immunol 216:259–274PubMedGoogle Scholar
  3. 3.
    Fujita S, Teramoto T, Watanabe M et al (1993) Anastomotic leakage after colorectal cancer surgery: a risk factor for recurrence and poor prognosis. Jpn J Clin Oncol 23:299–302PubMedGoogle Scholar
  4. 4.
    Garred P, Thiel S, Madsen HO et al (1992) Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol 90:517–521PubMedGoogle Scholar
  5. 5.
    Garred P, Strom J, Quist L et al (2003) Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 188:1394–1403CrossRefPubMedGoogle Scholar
  6. 6.
    Grandis JR, Snyderman CH, Johnson JT et al (1992) Postoperative wound infection: a poor prognostic sign for patients with head and neck cancer. Cancer 70:2166–2170Google Scholar
  7. 7.
    Herroeder S, Durieux ME, Hollmann MW (2002) Inflammatory responses after surgery. Hosp Med 63:99–103PubMedGoogle Scholar
  8. 8.
    Holmskov U, Thiel S, Jensenius JC (2003) Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21:547–578CrossRefPubMedGoogle Scholar
  9. 9.
    Jackson RM, Rice DH (1990) Wound infections and recurrence in head and neck cancer. Otolaryngol Head Neck Surg 102:331–333PubMedGoogle Scholar
  10. 10.
    Johnson HL, Chiou CC, Cho CT (1999) Applications of acute phase reactants in infectious diseases. J Microbiol Immunol Infect 32:73–82PubMedGoogle Scholar
  11. 11.
    Kakkanaiah VN, Shen GQ, Ojo-Amaize EA et al (1998) Association of low concentrations of serum mannose-binding protein with recurrent infections in adults. Clin Diagn Lab Immunol 5:319–321PubMedGoogle Scholar
  12. 12.
    Kehlet H, Nielsen HJ (1998) Impact of laparoscopic surgery on stress responses, immunofunction, and risk of infectious complications. New Horiz 6:S80–S88PubMedGoogle Scholar
  13. 13.
    Kilpatrick DC (2002) Mannan-binding lectin and its role in innate immunity. Transfus Med 12:335–352CrossRefPubMedGoogle Scholar
  14. 14.
    Kressner U, Graf W, Mahteme H et al (2002) Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 45:316–321CrossRefPubMedGoogle Scholar
  15. 15.
    Lipscombe RJ, Sumiya M, Hill AV et al (1992) High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1:709–715PubMedGoogle Scholar
  16. 16.
    Liu H, Jensen L, Hansen S et al (2001) Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol 53:489–497CrossRefPubMedGoogle Scholar
  17. 17.
    Mannick JA, Rodrick ML, Lederer JA (2001) The immunologic response to injury. J Am Coll Surg 193:237–244CrossRefPubMedGoogle Scholar
  18. 18.
    McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170:319–322CrossRefPubMedGoogle Scholar
  19. 19.
    McMillan DC, Elahi MM, Sattar N et al (2001) Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41:64–69CrossRefPubMedGoogle Scholar
  20. 20.
    McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90:215–219CrossRefPubMedGoogle Scholar
  21. 21.
    McMillan DC, Canna K, McArdle CS (2003) The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer. Br J Cancer 89:612–614CrossRefPubMedGoogle Scholar
  22. 22.
    Mynster T, Christensen IJ, Moesgaard F et al (2000) Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 87:1553–1562Google Scholar
  23. 23.
    Neth O, Hann I, Turner MW et al (2001) Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358:614–618CrossRefPubMedGoogle Scholar
  24. 24.
    Nielsen HJ, Christensen IJ, Moesgaard F et al (2002) Ranitidine as adjuvant treatment in colorectal cancer. Br J Surg 89:1416–1422CrossRefPubMedGoogle Scholar
  25. 25.
    Nozoe T, Matsumata T, Kitamura M et al (1998) Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 176:335–338CrossRefPubMedGoogle Scholar
  26. 26.
    Nozoe T, Matsumata T, Sugimachi K (2000) Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23:263–266PubMedGoogle Scholar
  27. 27.
    Petersen S, Freitag M, Hellmich G et al (1998) Anastomotic leakage: impact on local recurrence and survival in surgery of colorectal cancer. Int J Colorectal Dis 13:160–163CrossRefPubMedGoogle Scholar
  28. 28.
    Petersen SV, Thiel S, Jensen L et al (2001) An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 257:107–116CrossRefPubMedGoogle Scholar
  29. 29.
    Petersen SV, Thiel S, Jensenius JC (2001) The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133–149CrossRefPubMedGoogle Scholar
  30. 30.
    Peterslund NA, Koch C, Jensenius JC et al (2001) Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358:637–638CrossRefPubMedGoogle Scholar
  31. 31.
    Rasmussen LA, Nielsen HJ, Sorensen S et al (1995) Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis. J Am Coll Surg 181:138–144PubMedGoogle Scholar
  32. 32.
    Rodrigo JP, Suarez C (1998) Prognostic significance of postoperative wound infection on head and neck cancer. Otolaryngol Head Neck Surg 118:272–275PubMedGoogle Scholar
  33. 33.
    Siassi M, Hohenberger W, Riese J (2003) Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans 31:774–775CrossRefPubMedGoogle Scholar
  34. 34.
    Summerfield JA, Sumiya M, Levin M et al (1997) Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Br Med J 314:1229–1232Google Scholar
  35. 35.
    Swisher SG, Holmes EC, Hunt KK et al (1996) Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 112:341–348PubMedGoogle Scholar
  36. 36.
    Terai I, Kobayashi K, Fujita T et al (1993) Human serum mannose binding protein (MBP): development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metab Biol 50:111–119CrossRefPubMedGoogle Scholar
  37. 37.
    Thiel S, Holmskov U, Hviid L et al (1992) The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 90:31–35PubMedGoogle Scholar
  38. 38.
    Thiel S, Moller-Kristensen M, Jensen L et al (2002) Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 205:446–454PubMedGoogle Scholar
  39. 39.
    Wigmore SJ, McMahon AJ, Sturgeon CM et al (2001) Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 88:255–260CrossRefPubMedGoogle Scholar
  40. 40.
    Windsor AC, Klava A, Somers SS et al (1995) Manipulation of local and systemic host defence in the prevention of perioperative sepsis. Br J Surg 82:1460–1467PubMedGoogle Scholar
  41. 41.
    Ytting H, Jensenius JC, Christensen IJ et al (2004) Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol 39:674–679CrossRefPubMedGoogle Scholar
  42. 42.
    Zimmermann-Nielsen E, Baatrup G, Thorlacius-Ussing O et al (2002) Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn’s disease and colorectal cancer: suppressed activation by SLE plasma. Scand J Immunol 55:105–110CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Henriette Ytting
    • 1
  • Ib Jarle Christensen
    • 1
  • Jens Christian Jensenius
    • 2
  • Steffen Thiel
    • 2
  • Hans Jørgen Nielsen
    • 1
  1. 1.Department of Surgical Gastroenterology 435Hvidovre University HospitalHvidovreDenmark
  2. 2.Institute of Medical Microbiology and ImmunologyUniversity of AarhusAarhusDenmark

Personalised recommendations